news roundup
Greenphire’s ConneX solution adds visa and companion care services, whereby Greenphire coordinates the participant’s visa process and offers a qualified companion travel arrangements with a study participant.
CureDuchenne, a global nonprofit focused on finding a cure for Duchenne muscular dystrophy, will contribute patient-level clinical data to the Vivli platform, making it available to other researchers around the world. The Vivli platform currently hosts data from over 4,700 trials.
|
|
|
advertisement
Benchmark Your Clinical Development Plans and Drive Better Clinical Strategy
Thursday, January 30, 2020 at 11am EST | 10am PST | 4pm GMT | 5pm CET
Click here to register
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Koehler eClinical, a specialty contract research organization located in Breisgau, Germany, has opened additional offices in Mannheim, Germany, adding to its biostatisticians and statistical programming staff.
Articles
In this article, the authors discuss why and when suicidal ideation and behavior (SIB) should be monitored, compare the different approaches to assessing SIB, and present information supporting patient self-reported assessments as the preferred approach for detecting and monitoring SIB.
In this Q&A, John Rigg, senior principal, Predictive Analytics, Real World Solutions at IQVIA, discusses how patient disease modeling and diagnostic prediction is made possible with artificial intelligence and machine learning.
|
|
|
advertisement
Three Key Critical Considerations Before Embarking on Decentralized Trials
Available on Demand
Click here to register
|
|
|
Blog Posts
Health transparency organization, TranspariMED in Europe, has focused on poor summary results compliance in EudraCT, the EMA’s clinical trial register. But TranspariMED has taken a highly-visible “name-and-shame” approach on social media, and calling out non-reporting universities (and occasionally complimenting those that have raised their game) on Twitter.
In this article, regular contributor Moe Alsumidaie discusses his opinions on how automation and AI will transform the clinical trials industry.
| |
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|
